Prostate cancer after exogenous testosterone treatment for impotence.
Loughlin
K R
KR
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Richie
J P
JP
D000230:Adenocarcinoma / Q000139:chemically induced*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000139:chemically induced*; D013739:Testosterone / Q000009:adverse effects*
D013739:Testosterone